Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the emperor-preserved trial

HIGHLIGHTS

• who: Circulation and colleagues from the Department of Medicine, University of Mississippi School of Medicine, Jackson (JB., T.J.S.). National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Greece (G.F.). Boehringer Ingelheim International GmbH, Ingelheim, Germany (M. Brueckmann). Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany (M. Brueckmann). Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany (M. Böhm). Max Superspeciality Hospital, Saket, New Delhi, India (V.K.C.). Université de Lorraine, Inserm, Centre d'Investigations Cliniques, Plurithématique, and Inserm, CHRU, CRIN . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.